| 000094 (2011) |
Christoph Scherfler [Autriche] ; Birgit Frauscher [Autriche] ; Michael Schocke [Autriche] ; Alex Iranzo [Espagne] ; Viola Gschliesser [Autriche] ; Klaus Seppi [Autriche] ; Joan Santamaria [Espagne] ; Eduardo Tolosa [Espagne] ; Birgit Högl [Autriche] ; Werner Poewe [Autriche] | White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: A diffusion‐tensor imaging and voxel‐based morphometry study |
| 000194 (2011) |
Marcus M. Unger [Allemagne] ; Jens C. Möller [Allemagne] ; Katharina Mankel [Allemagne] ; Katrin Schmittinger [Allemagne] ; Karla M. Eggert [Allemagne] ; Maria Stamelou [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Katharina Bohne [Allemagne] ; Maren Bodden [Allemagne] ; Geert Mayer [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Johannes J. Tebbe [Allemagne] | Patients with idiopathic rapid‐eye‐movement sleep behavior disorder show normal gastric motility assessed by the 13C‐octanoate breath test |
| 000221 (2011) |
Ronald B. Postuma [Canada] ; Jean-François Gagnon [Canada] ; Mélanie Vendette [Canada] ; Catherine Desjardins [Canada] ; Jacques Y. Montplaisir [Canada] | Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder |
| 000381 (2011) |
Mélanie Vendette [Canada] ; Jean-François Gagnon [Canada] ; Jean-Paul Soucy [Canada] ; Nadia Gosselin [Canada] ; Ronald B. Postuma [Canada] ; Maria Tuineag [Canada] ; Isabelle Godin [Canada] ; Jacques Montplaisir [Canada] | Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder |
| 000967 (2009) |
Nadège Limousin [France] ; Eric Konofal [France] ; Elias Karroum [France] ; Ebba Lohmann [France] ; Ioannis Theodorou [France] ; Alexandra Dürr [France] ; Isabelle Arnulf [France] | Restless legs syndrome, rapid eye movement sleep behavior disorder, and hypersomnia in patients with two parkin mutations |
| 000A33 (2009) |
Jean-François Gagnon [Canada] ; Mélanie Vendette [Canada] ; Ronald B. Postuma [Canada] ; Catherine Desjardins [Canada] ; Jessica Massicotte-Marquez [Canada] ; Michel Panisset [Canada] ; Jacques Montplaisir [Canada] | Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease |
| 001433 (2005) |
Claudio Pacchetti [Italie] ; Raffaele Manni [Italie] ; Roberta Zangaglia [Italie] ; Francesca Mancini [Italie] ; Enrico Marchioni [Italie] ; Cristina Tassorelli [Italie] ; Michele Terzaghi [Italie] ; Maria Ossola [Italie] ; Emilia Martignoni [Italie] ; Arrigo Moglia [Italie] ; Giuseppe Nappi [Italie] | Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease |
| 000092 (2011) |
Michael Eller [Australie] ; David R. Williams | α-Synuclein in Parkinson disease and other neurodegenerative disorders |
| 000108 (2011) |
| Twenty Fifth Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders |
| 000142 (2011) |
Maria Sierra Pe A [États-Unis] ; Toby C. Yaltho [États-Unis] ; Joseph Jankovic [États-Unis] | Tardive dyskinesia and other movement disorders secondary to aripiprazole |
| 000198 (2011) |
Mathias Jucker [Allemagne, États-Unis] ; Lary C. Walker [États-Unis] | Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders |
| 000376 (2011) |
Ronald B. Postuma [Canada] ; Jacques Montplaisir [Canada] ; Paola Lanfranchi [Canada] ; Hélène Blais [Canada] ; Sylvie Rompré [Canada] ; Roberto Colombo [Italie] ; Jean-François Gagnon [Canada] | Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder |
| 000519 (2010) |
Y. K. Kim ; I-Y. Yoon ; J-M. Kim [Corée du Sud] ; S-H. Jeong ; K. W. Kim ; Y-K. Shin ; B. S. Kim ; S. E. Kim | The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder |
| 000526 (2010) |
Jean-François Gagnon [Canada] ; Ronald B. Postuma [Canada] ; Steve Joncas [Canada] ; Catherine Desjardins [Canada] ; Véronique Latreille [Canada] | The Montreal Cognitive Assessment: A screening tool for mild cognitive impairment in REM sleep behavior disorder |
| 000570 (2010) |
Bradley F. Boeve [États-Unis] | REM sleep behavior disorder |
| 000571 (2010) |
David H. Benninger [Suisse, États-Unis] ; Jan Michel [Suisse] ; Daniel Waldvogel [Suisse] ; Victor Candia [Suisse] ; Rositsa Poryazova [Suisse] ; Hubertus J. A. Van Hedel [Suisse] ; Claudio L. Bassetti [Suisse] | REM sleep behavior disorder is not linked to postural instability and gait dysfunction in Parkinson |
| 000578 (2010) |
| Program: Twenty Fourth Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders |
| 000788 (2010) |
Ronald B. Postuma [Canada] ; Paola A. Lanfranchi [Canada] ; Helene Blais [Canada] ; Jean-Francois Gagnon [Canada] ; Jacques Y. Montplaisir [Canada] | Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder |
| 000983 (2009) |
| Program: Twenty Third Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders |
| 000A13 (2009) |
Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Masaoki Iwanami [Japon] ; Keisuke Suzuki [Japon] ; Yuichi Inoue [Japon] ; Koichi Hirata [Japon] | Odor identification test as an indicator of idiopathic REM sleep behavior disorder |
| 000A65 (2009) |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Jacques Y. Montplaisir [Canada] | Idiopathic REM sleep behavior disorder in the transition to degenerative disease |
| 000C31 (2008) |
| Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders |
| 000D56 (2008) |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Katia Charland [Canada] ; Jacques Montplaisir [Canada] | Manifestations of Parkinson disease differ in association with REM sleep behavior disorder |
| 000F14 (2007) |
Birgit Frauscher [Autriche] ; Viola Gschliesser [Autriche] ; Elisabeth Brandauer [Autriche] ; Hanno Ulmer [Autriche] ; Cecilia M. Peralta [Autriche, Argentine] ; Jörg Müller [Autriche] ; Werner Poewe [Autriche] ; Birgit Högl [Autriche] | Video analysis of motor events in REM sleep behavior disorder |
| 000F66 (2007) |
Alex Iranzo [Espagne] ; Cynthia L. Comella [États-Unis] ; Joan Santamaria [Espagne] ; Wolfgang Oertel [Allemagne] | Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system |
| 000F97 (2007) |
Spiridon Papapetropoulos [États-Unis] ; Lina Shehadeh [États-Unis] ; Donald Mccorquodale [États-Unis] | Optimizing human post‐mortem brain tissue gene expression profiling in Parkinson's disease and other neurodegenerative disorders: From target “fishing” to translational breakthroughs |
| 001171 (2006) |
| Twentieth annual symposia on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders |
| 001172 (2006) |
Jeffrey L. Cummings [États-Unis] ; Kate Zhong [États-Unis] | Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies |
| 001305 (2006) |
S. G. Mueller [États-Unis] ; N. Schuff [États-Unis] ; M. W. Weiner [États-Unis] | Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS |
| 001614 (2004) |
Michael S. Okun [États-Unis] ; Jerrold L. Vitek [États-Unis] | Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies |
| 001616 (2004) |
Moussa B. H. Youdim [Israël] ; Galia Stephenson [Israël] ; Dorit Ben Shachar [Israël] | Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6‐Hydroxydopamine and Iron Chelators, Desferal and VK‐28 |
| 002167 (1996) |
A. Mouatt-Prigent [France] ; J. O. Karlsson [Suède] ; Yves Agid [France] ; E. C. Hirsch [France] | Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? |
| 002457 (1994) |
Jeswinder Sian ; David T. Dexter ; Andrew Lees (neurologue) [Royaume-Uni] ; Susan Daniel [Royaume-Uni] ; Yves Agid [France] ; France Javoy-Agid [France] ; Peter Jenner ; C. David Marsden [Royaume-Uni] | Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia |
| 002649 (1992) |
Dexter [Royaume-Uni] ; Peter Jenner [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia |
| 000135 (2011) |
Anne Pavy-Le Traon [France] ; Gerard Amarenco [France] ; Susanne Duerr [Autriche] ; Horacio Kaufmann [États-Unis] ; Heinz Lahrmann [Autriche] ; Stephanie R. Shaftman [États-Unis] ; François Tison [France] ; Gregor K. Wenning [Autriche] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Olivier Rascol [France] | The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension |
| 000136 (2011) |
Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease |
| 000137 (2011) |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease |
| 000148 (2011) |
Namiko Nishida [Japon] ; Tokiko Murakami [Japon] ; Kunihiro Kadoh [Japon] ; Rie Tohge [Japon] ; Miki Yamanegi [Japon] ; Hidemoto Saiki [Japon] ; Keita Ueda [Japon] ; Sadayuki Matsumoto [Japon] ; Masatsune Ishikawa [Japon] ; Jun A. Takahashi [Japon] ; Hiroki Toda [Japon] | Subthalamic nucleus deep brain stimulation restores normal rapid eye movement sleep in Parkinson's disease |
| 000150 (2011) |
J. Simon Lunn [États-Unis] ; Stacey A. Sakowski [États-Unis] ; Junguk Hur [États-Unis] ; Eva L. Feldman [États-Unis] | Stem cell technology for neurodegenerative diseases |
| 000248 (2011) |
C. Warren Olanow [États-Unis] ; Kathryn B. Wunderle [États-Unis] ; Karl Kieburtz [États-Unis] | Milestones in movement disorders clinical trials: Advances and landmark studies |
| 000249 (2011) |
Daniela Berg [Allemagne] ; Jonathan D. Steinberger [États-Unis] ; C. Warren Olanow [États-Unis] ; Thomas P. Naidich [États-Unis] ; Tarek A. Yousry [Royaume-Uni] | Milestones in magnetic resonance imaging and transcranial sonography of movement disorders |
| 000301 (2011) |
Daniel W. Neef [États-Unis] ; Alex M. Jaeger [États-Unis] ; Dennis J. Thiele [États-Unis] | Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases |
| 000347 (2011) |
S. Iraola-Guzmán [Espagne] ; X. Estivill [Espagne] ; R. Rabionet [Espagne] | DNA methylation in neurodegenerative disorders: a missing link between genome and environment? |
| 000367 (2011) |
Stanley Fahn [États-Unis] | Classification of movement disorders |
| 000419 (2011) |
A. E. Vanhaesebrouck [Royaume-Uni] ; G. D. Shelton [États-Unis] ; L. Garosi [Royaume-Uni] ; T. R. Harcourt-Brown [Royaume-Uni] ; J. Couturier [Royaume-Uni] ; S. Behr [Royaume-Uni] ; R. J. Harvey [Royaume-Uni] ; N. D. Jeffery [Royaume-Uni, États-Unis] ; K. Matiasek [Allemagne] ; W. F. Blakemore [Royaume-Uni] ; N. Granger [Royaume-Uni] | A Novel Movement Disorder in Related Male Labrador Retrievers Characterized by Extreme Generalized Muscular Stiffness |
| 000505 (2010) |
Hugo Vicente Miranda [Portugal] ; Tiago Fleming Outeiro [Portugal] | The sour side of neurodegenerative disorders: the effects of protein glycation |
| 000508 (2010) |
G. K Gi [Royaume-Uni] ; K P Bhatia [Royaume-Uni] ; E. Tolosa [Espagne] | The role of DAT-SPECT in movement disorders |
| 000538 (2010) |
Katharina Wulff [Royaume-Uni] ; Silvia Gatti [Suisse] ; Joseph G. Wettstein [Suisse] ; Russell G. Foster [Royaume-Uni] | Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease |
| 000576 (2010) |
Anna Martínez [Espagne] ; Manuel Portero-Otin [Espagne] ; Reinald Pamplona [Espagne] ; Isidre Ferrer [Espagne] | Protein Targets of Oxidative Damage in Human Neurodegenerative Diseases with Abnormal Protein Aggregates |
| 000700 (2010) |
Hyejin Hwang [États-Unis] ; Jianpeng Zhang [États-Unis] ; Kathryn A. Chung [États-Unis] ; James B. Leverenz [États-Unis] ; Cyrus P. Zabetian [États-Unis] ; Elaine R. Peskind [États-Unis] ; Joseph Jankovic [États-Unis] ; Zhen Su [États-Unis] ; Aneeka M. Hancock [États-Unis] ; Catherine Pan [États-Unis] ; Thomas J. Montine [États-Unis] ; Sheng Pan [États-Unis] ; John Nutt [États-Unis] ; Roger Albin [États-Unis] ; Marla Gearing [États-Unis] ; Richard P. Beyer [États-Unis] ; Min Shi [États-Unis] ; Jing Zhang [États-Unis] | Glycoproteomics in neurodegenerative diseases |
| 000714 (2010) |
Joseph H. Friedman [États-Unis] ; Guido Alves [Norvège] ; Peter Hagell [Suède] ; Johan Marinus [Pays-Bas] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] | Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease |
| 000744 (2010) |
L. K. Prashanth [Inde] ; S. Sinha [Inde] ; A. B. Taly [Inde] ; M. K. Vasudev [Inde] | Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases |
| 000831 (2010) |
M. Shioya ; S. Obayashi ; H. Tabunoki ; K. Arima ; Y. Saito ; T. Ishida [Japon] ; J. Satoh | Aberrant microRNA expression in the brains of neurodegenerative diseases: miR‐29a decreased in Alzheimer disease brains targets neurone navigator 3 |
| 000985 (2009) |
Bess Frost [États-Unis] ; Marc I. Diamond [États-Unis] | Prion-like mechanisms in neurodegenerative diseases |
| 000A20 (2009) |
Brit Mollenhauer [Allemagne] ; Claudia Trenkwalder [Allemagne] | Neurochemical biomarkers in the differential diagnosis of movement disorders |
| 000A86 (2009) |
Sarah Teixeira Camargos [Brésil] ; Leonardo Oliveira Dornas [Brésil] ; Parastoo Momeni [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Andrew Singleton [États-Unis] ; Francisco Cardoso [Brésil] | Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: Phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations |
| 000B06 (2009) |
Marian L. Evatt [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] ; Kelvin L. Chou [États-Unis] ; Ester Cubo [Espagne] ; Vanessa Hinson [États-Unis] ; Katie Kompoliti [États-Unis] ; Chengwu Yang [États-Unis] ; Werner Poewe [États-Unis] ; Olivier Rascol [Autriche] ; Cristina Sampaio [France, Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease |
| 000C40 (2008) |
Konstanze F. Winklhofer [Allemagne] ; Jörg Tatzelt [Allemagne] ; Christian Haass [Allemagne] | The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases |
| 000C59 (2008) |
Sonja Scholz [États-Unis, Royaume-Uni] ; Andrew Singleton [États-Unis] | Susceptibility genes in movement disorders |
| 000C76 (2008) |
Pablo Martinez-Martin [Espagne] ; Martine Visser [Pays-Bas] ; Carmen Rodriguez-Blazquez [Espagne] ; Johan Marinus [Pays-Bas] ; K. Ray Chaudhuri [Royaume-Uni] ; Jacobus J. Van Hilten [Pays-Bas] | SCOPA‐sleep and PDSS: Two scales for assessment of sleep disorder in Parkinson's disease |
| 000C84 (2008) |
R B Postuma [Canada] ; J F Gagnon [Canada] ; M. Vendette [Canada] ; K. Charland [Canada] ; J. Montplaisir [Canada] | REM sleep behaviour disorder in Parkinson’s disease is associated with specific motor features |
| 000C85 (2008) |
Elena Sinforiani [Italie] ; Claudio Pacchetti [Italie] ; Roberta Zangaglia [Italie] ; Chiara Pasotti [Italie] ; Raffaele Manni [Italie] ; Giuseppe Nappi [Italie] | REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: A two‐year follow up |
| 000E85 (2008) |
Elza Khusnutdinova [Russie] ; Irina Gilyazova [Russie] ; Eduardo Ruiz-Pesini [Espagne, États-Unis] ; Olga Derbeneva [États-Unis] ; Rita Khusainova [Russie] ; Irina Khidiyatova [Russie] ; Rim Magzhanov [Russie] ; Douglas C. Wallace [États-Unis] | A Mitochondrial Etiology of Neurodegenerative Diseases: Evidence from Parkinson's Disease |
| 000F38 (2007) |
Maurice A. Curtis [Suède] ; Richard L. M. Faull [Nouvelle-Zélande] ; Peter S. Eriksson [Suède] | The effect of neurodegenerative diseases on the subventricular zone |
| 000F54 (2007) |
Cynthia L. Comella [États-Unis] | Sleep disorders in Parkinson's disease: An overview |
| 000F68 (2007) |
G. Waldemar [Danemark] ; B. Dubois [France] ; M. Emre [Turquie] ; J. Georges [Luxembourg (pays)] ; I. G. Mckeith [Royaume-Uni] ; M. Rossor [Royaume-Uni] ; P. Scheltens [Pays-Bas] ; P. Tariska [Hongrie] ; B. Winblad [Suède] | Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline |
| 000F71 (2007) |
Ana Djarmati [Allemagne] ; Miodrag Gužvi [Allemagne, Serbie] ; Anne Grünewald [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; David K. Simon [États-Unis] ; Angela M. Kaindl [Allemagne] ; Peter Vieregge [Allemagne] ; Anders O. H. Nygren [Pays-Bas] ; Christian Beetz [Allemagne] ; Katja Hedrich [Allemagne] ; Christine Klein [Allemagne] | Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation‐dependent probe amplification |
| 001000 (2007) |
P. T. T. Ly [Canada] ; S. Singh [Canada] ; C. A. Shaw [Canada] | Novel environmental toxins: Steryl glycosides as a potential etiological factor for age‐related neurodegenerative diseases |
| 001075 (2007) |
Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie] | Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force |
| 001090 (2007) |
Gerhard Ransmayr [Autriche] | Constantin von Economo's contribution to the understanding of movement disorders |
| 001189 (2006) |
Lojze M. Smid ; Tomaz D. Vovko ; Mara Popovic ; Andrej Petri ; Vladimir Kepe ; Jorge R. Barrio ; Gaj Vidmar ; Mara Bresjanac | The 2,6‐Disubstituted Naphthalene Derivative FDDNP Labeling Reliably Predicts Congo Red Birefringence of Protein Deposits in Brain Sections of Selected Human Neurodegenerative Diseases |
| 001206 (2006) |
M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease |
| 001207 (2006) |
M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease |
| 001245 (2006) |
Plamen Gatev [États-Unis] ; Olivier Darbin [États-Unis] ; Thomas Wichmann [États-Unis] | Oscillations in the basal ganglia under normal conditions and in movement disorders |
| 001259 (2006) |
Michael T. Lin [États-Unis] ; M. Flint Beal [États-Unis] | Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases |
| 001368 (2006) |
Jorge J. Palop [États-Unis] ; Jeannie Chin [États-Unis] ; Lennart Mucke [États-Unis] | A network dysfunction perspective on neurodegenerative diseases |
| 001391 (2005) |
N. Déglon [France] ; P. Hantraye [France] | Viral vectors as tools to model and treat neurodegenerative disorders |
| 001393 (2005) |
Bart Post [Pays-Bas] ; Maruschka P. Merkus [Pays-Bas] ; Rob M. A. De Bie [Pays-Bas] ; Rob J. De Haan [Pays-Bas] ; Johannes D. Speelman [Pays-Bas] | Unified Parkinson's disease rating scale motor examination: Are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable? |
| 001460 (2005) |
S M Hague [Royaume-Uni] ; S. Klaffke [Royaume-Uni] ; O. Bandmann [Royaume-Uni] | Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease |
| 001512 (2005) |
K. Michno [Canada] ; D. Van De Hoef [Canada] ; H. Wu ; Gl Boulianne [Canada] | Demented flies? using Drosophila to model human neurodegenerative diseases |
| 001518 (2005) |
K. Stiasny-Kolster ; Y. Doerr ; J. C. Mo Ller ; H. Ho Ffken ; T. M. Behr ; W. H. Oertel ; G. Mayer [Allemagne] | Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT |
| 001567 (2004) |
P. K. Panegyres [Australie] | The contribution of the study of neurodegenerative disorders to the understanding of human memory |
| 001569 (2004) |
U. Fiszer ; B. Tomik ; P. Grzesiowski ; A. Krygowska-Wajs [Pologne] ; J. Walory ; M. Michałowska ; W. Palasik | The antibodies against Bordetella pertussis in sera of patients with Parkinson's disease and other non‐neurological diseases |
| 001586 (2004) |
E. I. Agorogiannis [Grèce] ; G. I. Agorogiannis [Grèce] ; A. Papadimitriou [Grèce] ; G. M. Hadjigeorgiou [Grèce] | Protein misfolding in neurodegenerative diseases |
| 001601 (2004) |
Kevin J. Barnham [Australie] ; Colin L. Masters [Australie] ; Ashley I. Bush [Australie, États-Unis] | Neurodegenerative diseases and oxidative stress |
| 001605 (2004) |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Carl Counsell [Portugal] ; Nir Giladi [Israël] ; Robert G. Holloway [États-Unis] ; Charity G. Moore [États-Unis] ; Gregor K. Wenning [Autriche] ; Melvin D. Yahr [États-Unis] ; Lisa Seidl [États-Unis] | Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease |
| 001617 (2004) |
Luigi Zecca [Italie] ; Moussa B. H. Youdim [Israël] ; Peter Riederer [Allemagne] ; James R. Connor [États-Unis] ; Robert R. Crichton [Belgique] | Iron, brain ageing and neurodegenerative disorders |
| 001618 (2004) |
Arezoo Campbell [États-Unis] | Inflammation, Neurodegenerative Diseases, and Environmental Exposures |
| 001680 (2003) |
Hyoung-Gon Lee [États-Unis] ; Robert B. Petersen [États-Unis] ; Xiongwei Zhu [États-Unis] ; Kazuhiro Honda [États-Unis] ; Gjumrakch Aliev [États-Unis] ; Mark A. Smith [États-Unis] ; George Perry [États-Unis] | Will Preventing Protein Aggregates Live Up to Its Promise as Prophylaxis Against Neurodegenerative Diseases? |
| 001684 (2003) |
Claudio Soto [Suisse] | Unfolding the role of protein misfolding in neurodegenerative diseases |
| 001685 (2003) |
Regina Katzenschlager [Royaume-Uni] ; Adriana Cardozo [Espagne] ; M. Rosario Avila Cobo [Espagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] | Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders |
| 001689 (2003) |
Jeffrey L. Cummings [États-Unis] | Toward a molecular neuropsychiatry of neurodegenerative diseases |
| 001702 (2003) |
Miquel Vila [États-Unis] ; Serge Przedborski [États-Unis] | Targeting programmed cell death in neurodegenerative diseases |
| 001734 (2003) |
Christopher Hawkes [Royaume-Uni] | Olfaction in neurodegenerative disorder |
| 001916 (2002) |
Diego Garcia-Borreguero [Espagne] ; Ana B. Caminero [Espagne] ; Yolanda De La Llave [Espagne] ; Oscar Larrosa [Espagne] ; Soledad Barrio [Espagne] ; Juan J. Granizo [Espagne] ; Juan A. Pareja [Espagne] | Decreased phasic EMG activity during rapid eye movement sleep in treatment‐naïve Parkinson's disease: Effects of treatment with levodopa and progression of illness |
| 001A16 (2001) |
S. Happe ; B. Schrödl ; M. Faltl [Autriche] ; C. Müller [Autriche] ; E. Auff [Autriche] ; J. Zeitlhofer | Sleep disorders and depression in patients with Parkinson's disease |
| 001B97 (2000) |
Jean A. Saint-Cyr [Canada] ; Lisa L. Trépanier [Canada] | Neuropsychologic assessment of patients for movement disorder surgery |
| 001C04 (2000) |
J. W. Husseman [États-Unis] ; D. Nochlin [États-Unis] ; I. Vincent [États-Unis] | Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases |
| 001D30 (1999) |
David F. Clayton ; Julia M. George | Synucleins in synaptic plasticity and neurodegenerative disorders |
| 001F22 (1998) |
J. W. Terryberry [États-Unis] ; G. Thor [États-Unis] ; J. B. Peter [États-Unis] | Autoantibodies in Neurodegenerative Diseases: Antigen-Specific Frequencies and Intrathecal Analysis |
